Birtamimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Birtamimab Usage And Synthesis

Uses

Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis[1].

References

[1] AGertz M, et, al. Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design. Journal home page for Blood. Volume 138, Supplement 1, 23 November 2021, Page 2754.

Birtamimab(1608108-91-3)Related Product Information

• Rulonilimab
• Duvortuxizumab
• Briakinumab
• Amubarvimab
• Trinbelimab
• Research Grade Clivatuzumab (DHD14205)
• Suptavumab
• Dresbuxelimab
• Adebrelimab
• Xeligekimab